Therefore, several lines of evidence suggest that not only does CPT1A have a possible causal role in T2D, an effect mediated by differential methylation patterns, but carbohydrate intake is crucial in inducing CPT1A methylation, thereby influencing the risk of developing MetS and T2D. The gene discussed is CPT1A; the disease is metabolic syndrome.